MSF challenges Gilead patent application in China

21-12-2017

MSF challenges Gilead patent application in China

Hailshadow / iStockphoto.com

Médecins Sans Frontières (MSF) has challenged a patent application filed by Gilead in China, claiming that the rejection of the patent would “pave the way towards the availability of affordable generic versions”. 


Médecins Sans Frontières, MSF, Gilead, hepatitis C, I-MAK, Sovaldi, sofosbuvir, SIPO, State Intellectual Property Office


LSIPR